Related Experiment Video
Updated: Nov 27, 2025
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.7K
The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?
Robert Ballotti1,2, Yann Cheli1,2, Corine Bertolotto3,4
1Université Côte d'Azur, Nice, France.
Molecular Cancer
|December 5, 2020
Summary
Microphthalmia-associated transcription factor (MITF) influences melanoma's immune evasion and resistance to immune checkpoint inhibitors (ICT). Understanding MITF's role could improve ICT efficacy and patient outcomes in melanoma treatment.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Immune checkpoint inhibitory therapy (ICT) shows limited clinical benefit in advanced melanomas due to resistance.
- Molecular drivers of resistance are known but not yet therapeutically actionable.
- A new treatment paradigm is needed to overcome resistance to ICT in melanoma.
Purpose of the Study:
- To review the role of microphthalmia-associated transcription factor (MITF) in melanoma biology and its interplay with the immune system.
- To explore how MITF contributes to immune evasion and resistance to ICT.
- To identify potential therapeutic strategies targeting MITF.
Main Methods:
- Literature review focusing on the function of MITF in melanoma.
- Analysis of MITF's role in regulating immune responses, antigen presentation, and tumor heterogeneity.
- Discussion of MITF's involvement in other cancers and immune cells.
Main Results:
- MITF controls melanoma differentiation, genome integrity, and antigen expression via the endolysosomal pathway and KARS1.
- MITF modulates PD-L1 and HVEM expression, impacting immune cell infiltration and activation.
- MITF drives melanoma cell plasticity and tumor heterogeneity, hindering immunotherapy.
Conclusions:
- MITF is a central regulator of immune responses in melanoma, influencing ICT resistance.
- Targeting MITF-immune system interactions may enhance ICT efficacy and lead to durable responses.
- Further research into MITF's role could personalize melanoma treatment.
Related Concept Videos
01:27Tumor Immunotherapy
899
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
899
02:17The Tumor Microenvironment
7.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.3K
01:27Cytotoxic T Cells-mediated Immune Response
6.2K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.2K
02:38Mitogens and the Cell Cycle
7.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K